| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PERRIGO CO PLC | 145,000 | 20,982,000 | 3.17% | ||
| 2 | ABIOMED INC | 220,000 | 19,862,000 | 3.00% | ||
| 3 | MEDTRONIC PLC | 249,000 | 19,153,000 | 2.90% | ||
| 4 | ALEXION PHARMACEUTIC | 100,000 | 19,075,000 | 2.88% | ||
| 5 | CVS HEALTH CORP | 180,000 | 17,599,000 | 2.66% | ||
| 6 | ALLERGAN PLC | 55,000 | 17,188,000 | 2.60% | ||
| 7 | ABBVIE INC | 246,000 | 14,573,000 | 2.20% | ||
| 8 | UNITEDHEALTH GROUP INC | 121,000 | 14,234,000 | 2.15% | ||
| 9 | PFIZER INC | 438,000 | 14,139,000 | 2.14% | ||
| 10 | AMGEN INC | 82,000 | 13,311,000 | 2.01% | ||
| 11 | CIGNA CORPORATION | 87,000 | 12,731,000 | 1.92% | ||
| 12 | BRISTOL MYERS SQUIBB CO | 183,000 | 12,589,000 | 1.90% | ||
| 13 | GILEAD SCIENCES INC | 124,000 | 12,548,000 | 1.90% | ||
| 14 | ALKERMES PLC SHS | 158,000 | 12,542,000 | 1.90% | ||
| 15 | CELGENE CORP | 104,000 | 12,455,000 | 1.88% | ||
| 16 | BIOMARIN | 118,000 | 12,362,000 | 1.87% | ||
| 17 | LILLY ELI & CO | 146,000 | 12,302,000 | 1.86% | ||
| 18 | ANTHEM INC | 88,000 | 12,271,000 | 1.86% | ||
| 19 | INCYTE | 110,000 | 11,930,000 | 1.80% | ||
| 20 | MCKESSON CORP | 59,000 | 11,637,000 | 1.76% | ||
| 21 | REGENERON PHARMACEUTICALS | 21,000 | 11,400,000 | 1.72% | ||
| 22 | AETNA INC NEW | 104,000 | 11,244,000 | 1.70% | ||
| 23 | WALGREENS BOOTS ALLIANCE INC | 132,000 | 11,240,000 | 1.70% | ||
| 24 | ZIMMER BIOMET HLDGS INC | 107,000 | 10,977,000 | 1.66% | ||
| 25 | HUMANA | 61,000 | 10,889,000 | 1.65% | ||
| 26 | ST JUDE | 175,000 | 10,810,000 | 1.63% | ||
| 27 | BECTON DICKINSON & CO | 69,000 | 10,632,000 | 1.61% | ||
| 28 | LABORATORY CORP AMER HLDGS | 81,000 | 10,015,000 | 1.51% | ||
| 29 | CENTENE CORP DEL | 149,000 | 9,806,000 | 1.48% | ||
| 30 | NEKTAR THERAPEUTICS COM | 581,000 | 9,790,000 | 1.48% | ||
| 31 | CARDINAL HEALTH INC | 104,000 | 9,284,000 | 1.40% | ||
| 32 | DEXCOM | 105,000 | 8,600,000 | 1.30% | ||
| 33 | HEALTH NET INC | 122,000 | 8,352,000 | 1.26% | ||
| 34 | MEDIVATION INC | 160,000 | 7,734,000 | 1.17% | ||
| 35 | HALOZYME THERAPEUTICS INC | 410,000 | 7,105,000 | 1.07% | ||
| 36 | ENDO INTL | 116,000 | 7,102,000 | 1.07% | ||
| 37 | VERTEX PHARMACEUT | 56,000 | 7,046,000 | 1.07% | ||
| 38 | CEMPRA INC | 226,000 | 7,035,000 | 1.06% | ||
| 39 | VALEANT PHARMACEUTICALS INTL | 69,000 | 7,014,000 | 1.06% | ||
| 40 | INTRA CELLULAR THERAPIES INC COM | 126,000 | 6,778,000 | 1.02% | ||
| 41 | HCA HOLDINGS INC | 96,000 | 6,492,000 | 0.98% | ||
| 42 | EXPRESS SCRIPTS HLDG CO | 74,000 | 6,468,000 | 0.98% | ||
| 43 | KERYX BIOPHARMACEUTICALS INCORPORATED | 1,233,000 | 6,227,000 | 0.94% | ||
| 44 | REVANCE THERAPEUTICS INC COM | 173,000 | 5,910,000 | 0.89% | ||
| 45 | JAZZ PHARMACEUTICALS PLC SHS USD | 42,000 | 5,904,000 | 0.89% | ||
| 46 | ALNYLAM PHARMACEUTICALS INC | 62,000 | 5,837,000 | 0.88% | ||
| 47 | RITE AID CORP | 678,000 | 5,316,000 | 0.80% | ||
| 48 | UNIVERSAL HLTH SVCS INC | 44,000 | 5,258,000 | 0.79% | ||
| 49 | BOSTON SCIENTIFIC CORP | 274,000 | 5,053,000 | 0.76% | ||
| 50 | CELLDEX THERAPEUTICS INC NEW | 320,000 | 5,018,000 | 0.76% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-004481, filed 2016.01.19).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
